Navigation Links
Everist Genomics Announces Worldwide Availability of OncoDefender™-CRC
Date:3/28/2011

ANN ARBOR, Mich., March 28, 2011 /PRNewswire/ -- Everist Genomics today announced the worldwide commercial availability of its OncoDefender-CRC colorectal cancer assay, the first and only molecular prognostic test capable of accurately predicting the risk of recurrence of cancer in patients previously treated with surgical resection of a Stage I/II colon cancer tumor or Stage I rectal cancer tumor.  The OncoDefender-CRC test examines expression levels of a panel of genes extracted from formalin-fixed paraffin-embedded cancer tissue taken at the time of surgery, and uses a proprietary computer-generated decision rule to identify patients who are at risk of recurrence.  Patients identified by OncoDefender-CRC at high-risk of cancer recurrence may benefit from adjuvant therapy or other more aggressive treatment options, as reported at the 2011 American Society of Clinical Oncology (ASCO) meeting. (1)

(Logo: https://photos.prnewswire.com/prnh/20110110/NY26865LOGO)

"We are pleased to deliver a new molecular prognostic test capable of assessing recurrence risk in early stage colorectal cancer patients, including the neglected stage I subset, where the lack of positive predictive prognostics presents a significant unmet need," said Prasad Sunkara, Ph.D., Chief Executive Officer of Everist Genomics.  OncoDefender-CRC was developed through extensive clinical research and assay validation studies involving over 500 patients from around the world.  "OncoDefender-CRC will help physicians make patient management decisions that promptly and reliably direct the most effective treatment to those individual Stage I/II colon cancer and Stage I rectal cancer patients at high risk for tumor recurrence, while minimizing the exposure of low-risk patients to unnecessary, costly, and potentially toxic chemotherapy and/or radiotherapy."

Traditional standards for assessing a patient's risk of cancer recurrence have depended solely on the cancer's a
'/>"/>

SOURCE Everist Genomics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Genetics Squared Changes Name To Everist Genomics
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
5. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
6. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
7. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
8. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
9. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
10. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
11. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 The Canadian Society for ... specific tests, treatments or procedures that are commonly ... as part of Choosing Wisely Canada.  The list ... support conversations between patients and physicians about what ... Society for Vascular Surgery,s list identified the following ...
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5tzcx6/specialty_enzymes ) has ... Global Strategic Business Report" report to their offering. ... following End-Use Applications: Pharmaceutical & Diagnostics, Research/ Biotechnology, and ... US, Canada , Japan ... Asia-Pacific , Latin America , ...
(Date:6/2/2015)... PITTSBURGH , June 2, 2015 ... technology (HIT) consulting firm, today announced the celebration ... organizations served throughout the U.S., since its inception ... for a skillful workforce in the healthcare technology ... resources with a company-wide dedication to facilitating clients, ...
Breaking Medicine Technology:As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4Specialty Enzymes - Global Strategic Business Report 2015: Indispensable to the Pharmaceutical Industry 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 3
... March 7, 2012   Leading events organiser UBM ... announced that CPhI Japan will return to its traditional March ... held on a smaller scale in Osaka, Japan to accommodate ... to stabilize, Tokyo will once again play host to CPhI ...
... 7, 2012  ThermoGenesis Corp. (NASDAQ: KOOL ) a ... store adult stem cells, said today that it will be ... Stock Conference on Wednesday, March 14. The presentation ... begin at 10:30 a.m., Pacific Daylight Time (1:30 p.m., Eastern ...
Cached Medicine Technology:CPhI Japan Returns to Tokyo for 2012 2CPhI Japan Returns to Tokyo for 2012 3
(Date:6/2/2015)... On Wednesday, May 27, 2015, professional driver, Brian Smith, drove ... 207.9 mph. In the process, Hennessey’s potent pony car ... mark. Jay Leno was on hand to witness the ... Garage, which will air on CNBC later this year. , ... oval at the Continental Tire Proving Grounds located in Uvalde, ...
(Date:6/2/2015)... UCLA Health and Exer have completed ... and expand urgent care services in Los Angeles County. ... University of California Board of Regents and the Exer ... Health to purchase a minority share of four existing ... Park and Northridge and creates opportunity to grow and ...
(Date:6/2/2015)... 02, 2015 TMG Health, the leading ... plans in the Medicare Advantage, Medicare Part D, and ... and exhibitor at AHIP’s Institute 2015, the annual meeting ... The conference will be held June 3-5 in Nashville, ... offer opportunities for attendees to schedule private discussions with ...
(Date:6/2/2015)... 02, 2015 On October 1, 2015 ... for another delay. , On Monday, June 1st ... for the House Ways and Means Committee, and 12 ... for Medicare and Medicaid Services, urging the administration to ... rolls out ICD-10. ICD-10 is the newest coding system ...
(Date:6/2/2015)... Los Angeles, California (PRWEB) June 02, 2015 ... packaging, sealers and sorbent systems, has announced the ... combat accidental ingestion of poisons by children, especially ... to ASTM D3475 standards and tested to CFR ... President/Technical Director Kevin Cullen. , Looks Like Candy, ...
Breaking Medicine News(10 mins):Health News:774 HP Hennessey Mustang Tested to 207.9 mph 2Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:TMG Health to Sponsor and Exhibit at AHIP’s Institute 2015 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2
... Nov. 5 One of Fayette,County,s largest employers will ... help of an $8.4 million, 20-year investment by the ... each year through the,Fayette County Redevelopment Authority, on behalf ... The funds will be used to jump start ...
... eye care facility in Tanzania to,be honored with ... Nov. 5 Today, Seva,Foundation proudly honors the ... preventable blindness around the world -- Dr. Paul,Courtright ... Center for Community Ophthalmology (KCCO),which Courtright and Lewallen ...
... published in the journal of Minerva Cardioangiologica reveals Pycnogenol, ... reduces jetlag in passengers by nearly 50 percent. The ... a scoring system, showed Pycnogenol lowered symptoms of jetlag ... in both healthy individuals and hypertensive patients. Passengers also ...
... Nov. 5 Americans United for Life,(AUL) today ... initiatives. The election saw pro-life ballot initiatives on,abortion ... legalizing physician-assisted suicide in Washington state and,destructive embryonic ... Dr. Charmaine Yoest, President & CEO of AUL ...
... physicians look forward to health system reform in 2009, ... by Nancy Nielsen, M.D., AMA President:, "The American ... for the presidency of the United States. He has,proposed ... and made it a,central issue in his campaign., ...
... 5 Dynamics Research,Corporation (Nasdaq: DRCO ... engineering, technology and information technology services and,solutions ... that it,received an $11.4 million task order ... (TEAMS) indefinite delivery and indefinite,quantity (ID/IQ) contract, ...
Cached Medicine News:Health News:State to Invest $8.4 Million in Uniontown Hospital's Expansion 2Health News:Seva Foundation Recognizes Paul Courtright and Susan Lewallen for Their Commitment to Blindness Prevention 2Health News:Seva Foundation Recognizes Paul Courtright and Susan Lewallen for Their Commitment to Blindness Prevention 3Health News:Study shows pine bark reduces jetlag 2Health News:Study shows pine bark reduces jetlag 3Health News:Americans United for Life Assesses State Ballot Initiative Outcomes, Predicts Regrouping and Strong Comeback in Next Election Cycle for Life Issues 2Health News:Americans United for Life Assesses State Ballot Initiative Outcomes, Predicts Regrouping and Strong Comeback in Next Election Cycle for Life Issues 3Health News:AMA Congratulates President-Elect Obama 2Health News:Dynamics Research Corporation Awarded $11.4 Million Medical Healthcare Program Management Contract 2Health News:Dynamics Research Corporation Awarded $11.4 Million Medical Healthcare Program Management Contract 3
Standard 20x long working distance objectives for greater magnifications of your microtools....
... An economical laboratory tissue culture microscope, the ... expand their applications. Olympus has taken the ... CKX41. Fluorescence can be used with an ... can be carried out on the CKX41 ...
... Eclipse TE2000S is an advanced ... research. It's exclusive CFI60 optical ... high numerical aperatures and longer ... inverted microscope to take full ...
... new Eclipse TS-100 is an innovative ... high quality tool complements any research ... CFI60 optics offer brilliant, sharp ... superb optical performance with high resolution ...
Medicine Products: